JP2021507682A5 - - Google Patents

Download PDF

Info

Publication number
JP2021507682A5
JP2021507682A5 JP2020524832A JP2020524832A JP2021507682A5 JP 2021507682 A5 JP2021507682 A5 JP 2021507682A5 JP 2020524832 A JP2020524832 A JP 2020524832A JP 2020524832 A JP2020524832 A JP 2020524832A JP 2021507682 A5 JP2021507682 A5 JP 2021507682A5
Authority
JP
Japan
Prior art keywords
binding
polypeptide
cargo molecule
domain
mirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021507682A (ja
JP7077404B2 (ja
Filing date
Publication date
Priority claimed from GB1718471.4A external-priority patent/GB2568255A/en
Application filed filed Critical
Publication of JP2021507682A publication Critical patent/JP2021507682A/ja
Publication of JP2021507682A5 publication Critical patent/JP2021507682A5/ja
Priority to JP2022080936A priority Critical patent/JP2022113690A/ja
Application granted granted Critical
Publication of JP7077404B2 publication Critical patent/JP7077404B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524832A 2017-11-08 2018-11-08 Rna治療薬を含むエクソソーム Expired - Fee Related JP7077404B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022080936A JP2022113690A (ja) 2017-11-08 2022-05-17 Rna治療薬を含むエクソソーム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1718471.4A GB2568255A (en) 2017-11-08 2017-11-08 Exosomes comprising RNA therapeutics
GB1718471.4 2017-11-08
PCT/EP2018/080681 WO2019092145A1 (en) 2017-11-08 2018-11-08 Exosomes comprising rna therapeutics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022080936A Division JP2022113690A (ja) 2017-11-08 2022-05-17 Rna治療薬を含むエクソソーム

Publications (3)

Publication Number Publication Date
JP2021507682A JP2021507682A (ja) 2021-02-25
JP2021507682A5 true JP2021507682A5 (cg-RX-API-DMAC7.html) 2021-12-23
JP7077404B2 JP7077404B2 (ja) 2022-05-30

Family

ID=60664781

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020524832A Expired - Fee Related JP7077404B2 (ja) 2017-11-08 2018-11-08 Rna治療薬を含むエクソソーム
JP2022080936A Pending JP2022113690A (ja) 2017-11-08 2022-05-17 Rna治療薬を含むエクソソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022080936A Pending JP2022113690A (ja) 2017-11-08 2022-05-17 Rna治療薬を含むエクソソーム

Country Status (18)

Country Link
US (1) US20210369865A1 (cg-RX-API-DMAC7.html)
EP (2) EP3973989A1 (cg-RX-API-DMAC7.html)
JP (2) JP7077404B2 (cg-RX-API-DMAC7.html)
KR (1) KR102431418B1 (cg-RX-API-DMAC7.html)
CN (1) CN111629760B (cg-RX-API-DMAC7.html)
AU (1) AU2018365299B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020006960A2 (cg-RX-API-DMAC7.html)
CA (1) CA3082194C (cg-RX-API-DMAC7.html)
DK (1) DK3706796T3 (cg-RX-API-DMAC7.html)
ES (1) ES2899857T3 (cg-RX-API-DMAC7.html)
GB (1) GB2568255A (cg-RX-API-DMAC7.html)
IL (1) IL274125B (cg-RX-API-DMAC7.html)
MX (1) MX389425B (cg-RX-API-DMAC7.html)
PT (1) PT3706796T (cg-RX-API-DMAC7.html)
RU (1) RU2020118554A (cg-RX-API-DMAC7.html)
SG (1) SG11202004199PA (cg-RX-API-DMAC7.html)
WO (1) WO2019092145A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202002537B (cg-RX-API-DMAC7.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019122461A (ja) * 2018-01-12 2019-07-25 株式会社三洋物産 遊技機
JP2019122462A (ja) * 2018-01-12 2019-07-25 株式会社三洋物産 遊技機
JP2019136400A (ja) * 2018-02-14 2019-08-22 株式会社三洋物産 遊技機
JP2019136401A (ja) * 2018-02-14 2019-08-22 株式会社三洋物産 遊技機
JP2019136399A (ja) * 2018-02-14 2019-08-22 株式会社三洋物産 遊技機
JP2019136398A (ja) * 2018-02-14 2019-08-22 株式会社三洋物産 遊技機
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
CN108753833B (zh) * 2018-05-28 2021-12-03 上海海洋大学 斑马鱼notch3基因突变体的制备方法
GB201810301D0 (en) * 2018-06-22 2018-08-08 Evox Therapeutics Ltd Combinatorial gene therapy
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics
US20220411785A1 (en) * 2019-11-15 2022-12-29 The University Of Tokyo Library of barcoded extracellular vesicles
CN115176015A (zh) * 2020-02-28 2022-10-11 国立大学法人金泽大学 免疫调节法、免疫调节用核酸组合物及其用途
US20230096378A1 (en) 2020-03-12 2023-03-30 Institute For Basic Science Composition for inducing apoptosis of cells having genomic sequence variation and method for inducing apoptosis of cells by using composition
CN111424017B (zh) * 2020-03-27 2022-08-09 暨南大学 一种装载shRNA的外泌体及其构建方法与应用
WO2021207126A1 (en) * 2020-04-06 2021-10-14 The Trustees Of Dartmouth College Compositions and methods for treating bacterial infections
WO2021223659A1 (en) * 2020-05-06 2021-11-11 Nanjing Iaso Biotherapeutics Co., Ltd. Extracellular vesicles targeting cancer cells and uses thereof
AU2021270587A1 (en) * 2020-05-14 2022-12-08 Modernatx, Inc. LNP compositions comprising an mRNA therapeutic and an effector molecule
CN111647045B (zh) * 2020-06-17 2022-05-27 清华大学深圳国际研究生院 一种cd133拮抗多肽及其衍生物与应用
GB202010278D0 (en) 2020-07-03 2020-08-19 Evox Therapeutics Ltd Extracellular vesicles with improved half-life
EP4181935A1 (en) * 2020-07-20 2023-05-24 Brainstorm Cell Therapeutics Ltd. Methods and compositions for treating lung conditions
MX2023001109A (es) 2020-07-27 2023-04-24 Anjarium Biosciences Ag Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas.
CN112285195B (zh) * 2020-10-27 2021-08-10 江南大学 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法
CN112626068B (zh) * 2020-12-21 2021-12-03 徐州医科大学 一种靶向Notch1基因的LncRNA及其应用
WO2022206781A1 (zh) * 2021-03-30 2022-10-06 南京大学 一种用于治疗结肠炎的rna递送系统
GB202105925D0 (en) 2021-04-26 2021-06-09 Evox Therapeutics Ltd Modified extracellular vesicles (EVs) with improved half-life
EP4364728A4 (en) * 2021-06-30 2025-07-02 Primoris Therapeutics Co Ltd PHARMACEUTICAL COMPOSITION CONTAINING NATURAL OR ARTIFICIAL CELL-DERIVED NANOVESICLES LOADED WITH AN ANTISENSE OLIGONUCLEOTIDE-BASED DRUG
WO2023284380A1 (zh) * 2021-07-15 2023-01-19 呈诺再生医学科技(北京)有限公司 细胞作为基因治疗的载体在临床中的应用
CA3226019A1 (en) 2021-07-20 2023-01-26 Ags Therapeutics Sas Extracellular vesicles from microalgae, their preparation, and uses
US20240360198A1 (en) * 2021-09-01 2024-10-31 National University Corporation Kanazawa University Immunoregulatory method, nucleic acid composition for immunoregulation, and use thereof
WO2023144127A1 (en) 2022-01-31 2023-08-03 Ags Therapeutics Sas Extracellular vesicles from microalgae, their biodistribution upon administration, and uses
CN114569721B (zh) * 2022-02-25 2023-03-24 浙江大学 载药的胞外囊泡在制备治疗肥胖或减轻肥胖相关代谢指标的药物中的应用
WO2023232976A1 (en) 2022-06-03 2023-12-07 Ags Therapeutics Sas Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
GB202210861D0 (en) * 2022-07-25 2022-09-07 Univ Oxford Innovation Ltd Loaded extracellular vesicle
JP2025535944A (ja) 2022-10-24 2025-10-30 エイジーエス・セラピューティクス・ソシエテ・パール・アクシオン・サンプリフィエ 微細藻類由来の細胞外小胞、鼻腔内投与時のそれらの生体内分布、及びそれらの使用
WO2024112359A1 (en) * 2022-11-21 2024-05-30 The Johns Hopkins University Genetic enhancement of exosome production
EP4434534A1 (en) 2023-03-22 2024-09-25 ADvantage Therapeutics, Inc. Klotho mrna
WO2024194423A1 (en) 2023-03-23 2024-09-26 Ags Therapeutics Sas Extracellular vesicles from microalgae, their use for vaccines and for immunomodulation
CN119301256A (zh) * 2023-05-08 2025-01-10 天津外泌体科技有限公司 外囊泡融合蛋白及其应用
GB202307239D0 (en) 2023-05-15 2023-06-28 Evox Therapeutics Ltd Gene therapies for Phenylketonuria
EP4784736A2 (en) 2023-09-29 2026-08-05 Evox Therapeutics Limited Polypeptides comprising inteins for engineered evs
CN120393034A (zh) * 2023-11-10 2025-08-01 深圳市茵冠生物科技有限公司 一种寡核苷酸偶联物及含其外泌体偶联物与应用
WO2025176843A1 (en) 2024-02-21 2025-08-28 Ags Therapeutics Sas Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof
WO2025196641A1 (ru) * 2024-03-19 2025-09-25 Биоплатформ Гмбх Гибридные частицы, способ их получения и применение
WO2025247999A1 (en) 2024-05-30 2025-12-04 Conveyxo Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles
EP4656187A1 (en) 2024-05-30 2025-12-03 ConvEyXo Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles
WO2026095803A1 (en) 2024-11-04 2026-05-07 Umc Utrecht Holding B.V. Sirna delivery with biological vectors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2419144T (pt) 2009-04-17 2019-09-16 Univ Oxford Innovation Ltd Composição para a administração de material genético
CA2798703A1 (en) * 2010-05-10 2011-11-17 The Regents Of The University Of California Endoribonuclease compositions and methods of use thereof
WO2013188638A2 (en) * 2012-06-15 2013-12-19 The Regents Of The University Of California Endoribonucleases and methods of use thereof
WO2015002956A1 (en) 2013-07-01 2015-01-08 Ohio State Innovation Foundation Exosome delivery system
US10538570B2 (en) * 2013-09-30 2020-01-21 Northwestern University Targeted and modular exosome loading system
CN111206032B (zh) * 2013-12-12 2024-07-19 布罗德研究所有限公司 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
CA3091771C (en) * 2015-03-13 2026-04-28 The Jackson Laboratory A three-component crispr/cas complex system and uses thereof
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10624849B2 (en) * 2015-09-28 2020-04-21 Northwestern University Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
EP3440090B1 (en) * 2016-04-06 2022-09-28 Ohio State Innovation Foundation Rna ligand-displaying exosomes for specific delivery of therapeutics to cell by rna nanotechnology
GB201609216D0 (en) 2016-05-25 2016-07-06 Evox Therapeutics And Isis Innovation Ltd Exosomes comprising therapeutic polypeptides
AU2018320864B2 (en) * 2017-08-22 2024-02-22 Napigen, Inc. Organelle genome modification using polynucleotide guided endonuclease

Similar Documents

Publication Publication Date Title
RU2020118554A (ru) Экзосомы, содержащие рнк-терапевтические средства
RU2018145738A (ru) Экзосомы, содержащие терапевтические полипептиды
JP2019520852A5 (cg-RX-API-DMAC7.html)
US20240417722A1 (en) Compositions and methods for immunooncology
JP7776176B2 (ja) 環状rnaを調製するための構築物及び方法
RU2748281C2 (ru) Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин
KR101950747B1 (ko) Cld18a2를 표적으로 하는 면역 작동 세포 및 그 제조방법과 용도
AR120566A1 (es) Receptores de antígeno quiméricos y sus usos
JP2019524745A5 (cg-RX-API-DMAC7.html)
CN106554414A (zh) 抗cd19全人抗体以及靶向cd19的免疫效应细胞
CN110291198A (zh) 经修饰的指导rna
JP2006519763A5 (cg-RX-API-DMAC7.html)
WO2014180306A1 (zh) 编码gpc3嵌合抗原受体蛋白的核酸及表达gpc3嵌合抗原受体蛋白的t淋巴细胞
CN114539422B (zh) 核酸多聚化介导的多价蛋白药物和疫苗的构建方法及应用
WO2020225392A1 (en) Exosome comprising stabilized rna therapeutics
CN115925948A (zh) 一种抗cd22纳米抗体及其应用
KR20240006603A (ko) 변형된 리보핵산 및 이의 용도
CN119306837B (zh) 一种抗cd276的纳米抗体及其应用
EP4561536A1 (en) Loaded extracellular vesicle
IL322949A (en) Systems targeting PSMA and CA9
CN101531718B (zh) 抗VEGFR-2抗体嵌合Fab抗体片段及其制备方法、应用
CN113549157B (zh) 双靶向嵌合抗原受体及其应用
JP2024511839A (ja) 少なくとも2つの異なる核酸を担持した細胞外小胞
AU2024370741A1 (en) Rna for in vivo transfection with increased expression
CN117964760A (zh) 抗人cll1/cd3的双特异性抗体及其应用